KYG397141030 - Common Stock
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday.
Hong Kong-based SPAC HH&L (HHLA) said in a filing that it has terminated its planned merger with liquid biopsy developer DiaCarta. Read more here.
PLEASNTON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious...
Abstracts demonstrating XNA technology’s improvements to assay sensitivity across different technology platforms and support for use in companion...
PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the...
DiaCarta Starts to Receive Samples for Oncuria® Bladder Cancer Test at its CLIA Lab PLEASANTON, Calif. and LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE)...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...